Liposomal factor VIII as an efficient pharmaceutical system for the treatment of hemophilia
Objective(s): Currently, the most important treatment approach for hemophilia type A is recombinant Factor VIII. However, due to its low retention time in the blood, the patients usually need successive injections. In addition, neutralization of injected proteins by antibodies complicates treatment....
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Mashhad University of Medical Sciences
2024-06-01
|
| মালা: | Iranian Journal of Basic Medical Sciences |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ijbms.mums.ac.ir/article_23891_294e60660171fdf99ae5e7519656baf7.pdf |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|